Coldstream Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Coldstream Capital Management's HALO Position: Q2 2026 in Review
Coldstream Capital Management reduced its Halozyme (HALO) stake by 2.6% in Q2 2026, selling an estimated $15.5K and leaving 8,635 shares worth $676K. The position accounts for 0.01% of the portfolio, ranked #618.
Coldstream Capital Management first reported a position in HALO in Q2 2022 and has held it in 13 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Coldstream Capital Management held 8,635 shares of Halozyme worth $676K as of Q2 2026.
- Coldstream Capital Management sold 228 Halozyme shares in Q2 2026, an estimated $15.5K.
- Halozyme made up 0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #618 holding.
- Coldstream Capital Management first reported a position in Halozyme in Q2 2022 and has held it in 13 quarters since.
- 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.